The gut microbiota (microbiome) in cardiovascular disease and its therapeutic regulation

MM Rahman, F Islam, MH -Or-Rashid… - Frontiers in cellular …, 2022 - frontiersin.org
In the last two decades, considerable interest has been shown in understanding the
development of the gut microbiota and its internal and external effects on the intestine, as …

[HTML][HTML] Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies

MM Rahman, MR Islam, S Shohag, MT Ahasan… - Biomedicine & …, 2022 - Elsevier
Cancer is the world's second-leading cause of death, and the involvement of microbes in a
range of diseases, including cancer, is well established. The gut microbiota is known to play …

Evolution of Helicobacter pylori Resistance to Antibiotics: A Topic of Increasing Concern

L Boyanova, P Hadzhiyski, R Gergova, R Markovska - Antibiotics, 2023 - mdpi.com
Antibiotic resistance among Helicobacter pylori strains is the major cause of eradication
failure. Resistance prevalence is dynamic and can greatly vary among countries over the …

Evolution of Diagnostic Methods for Helicobacter pylori Infections: From Traditional Tests to High Technology, Advanced Sensitivity and Discrimination Tools

AI Cardos, A Maghiar, DC Zaha, O Pop, L Fritea… - Diagnostics, 2022 - mdpi.com
Rapid diagnosis and treatment application in the early stages of H. pylori infection plays an
important part in inhibiting the transmission of this infection as this bacterium is involved in …

An overview of antimicrobial stewardship optimization: the use of antibiotics in humans and animals to prevent resistance

MM Rahman, MA Alam Tumpa, M Zehravi, MT Sarker… - Antibiotics, 2022 - mdpi.com
Antimicrobials are a type of agent widely used to prevent various microbial infections in
humans and animals. Antimicrobial resistance is a major cause of clinical antimicrobial …

A review on the research progress on non-pharmacological therapy of Helicobacter pylori

Q Luo, N Liu, S Pu, Z Zhuang, H Gong… - Frontiers in …, 2023 - frontiersin.org
Helicobacter pylori is a pathogenic microorganism that mainly resides in the human stomach
and is the major cause of chronic gastritis, peptic ulcer and gastric cancer. Up to now, the …

Carbocisteine as a modulator of Nrf2/HO-1 and NFκB interplay in rats: new inspiration for the revival of an old drug for treating ulcerative colitis

AM Abdelhamid, ME Youssef, S Cavalu… - Frontiers in …, 2022 - frontiersin.org
Ulcerative colitis (UC), an inflammatory bowel disease, is a chronic condition of a
multifaceted pathophysiology. The incidence of UC is increasing internationally. The current …

RETRACTED ARTICLE: Helicobacter pylori strains isolated from raw poultry meat: frequency and molecular characteristics

T Piri-Gharaghie, G Ghajari… - Scientific Reports, 2023 - nature.com
Even though Helicobacter pylori (H. pylori) is a serious pathogen, its origin is unknown.
Poultry (Chicken, Turkey, Quebec, Goose, and Ostrich) are consumed as a regular protein …

The effects and mechanisms of natural products on Helicobacter pylori eradication

R Deng, X Chen, S Zhao, Q Zhang… - Frontiers in Cellular and …, 2024 - frontiersin.org
Helicobacter pylori (H. pylori) eradication is pivotal for alleviating gastric mucosal
inflammation and preventing the progression of gastric diseases. While antibiotic-based …

Comment on Villalva et al. Antioxidant, Anti-Inflammatory, and Antibacterial Properties of an Achillea millefolium L. Extract and Its Fractions Obtained by Supercritical Anti-Solvent Fractionation against …

R Frański, M Beszterda-Buszczak - Antioxidants, 2023 - mdpi.com
Villalva et al. evaluated the potential utility of an Achillea millefolium (yarrow) extract in the
control of H. pylori infection. The agar-well diffusions bioassay was applied to determine the …